How should we treat early unfavourable Hodgkin Lymphoma?


E-session 612

Expert
Wendy Osborne'
The Newcastle Upon Tyne NHS Foundation Trust
Newcastle, United Kingdom
Discussant
Astrid Pavlovsky'
Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

This e-Session is part of the following pathway(s):
07
Apr 2022